Senores Pharma Board Approves ESOP, New Director, Subsidiary

Senores Pharmaceuticals Limited announced outcomes from its Board Meeting held on August 26, 2026. Key decisions included the appointment of Mrs. Shilpa Sharma as Company Secretary and Compliance Officer, and Mr. Viranchi Arvindbhai Shah as Non-Executive Additional Director (Independent). The Board also approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026 (ESOS 2026), subject to shareholder and regulatory approvals. Furthermore, the company received approval for the incorporation of a Wholly Owned Subsidiary in Mexico to support international market expansion. Authorized officers were appointed to determine materiality of events and make disclosures to stock exchanges.